Skip to main content

Table 3 Adverse events experienced by patients receiving adjuvant TS-1 treatment

From: Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment

Events Patients, n = 40 (%)
Grade I Grade II Grade III Grade IV Total
Skin pigmentation 18 (45) 4 (10) 0 0 22 (55)
Diarrhea 1 (2.5) 7 (17.5) 2 (5) 1 (2.5) 11 (27.5)
Fatigue 1 (2.5) 2 (5) 0 0 3 (7.5)
Vomiting 3 (7.5) 2 (5) 1 (2.5) 0 6 (15)
Stomatitis 0 2 (5) 3 (7.5) 0 5 (12.5)
Anorexia 5 (12.5) 1 (2.5) 1 (2.5) 0 7 (17.5)
Alopecia 3 (7.5) 0 0 0 3 (7.5)
Dizziness 8 (20) 2 (5) 1 (2.5) 0 11 (27.5)
Leukopenia 1 (2.5) 5 (12.5) 2 (5) 0 8 (20)
Thrombocytopenia 2 (5) 0 0 0 2 (5)
Anemia 1 (2.5) 4 (10) 0 0 5 (12.5)